Instructions for authors
About the Journal
Clinical Toxicology is an international, peer-reviewed journal publishing high-quality, original research. Please see the journal's Aims & Scope for information about its focus and peer-review policy.
Please note that this journal only publishes manuscripts in English.
Clinical Toxicology accepts the following types of article: Clinical Research, Basic Research, Poison Centre Research, Short Communication, Review, Toxicological History, Teaching Case, Letter to the Editor, Commentary.
Open Access
You have the option to publish open access in this journal via our Open Select publishing program. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership and impact of your research. Articles published Open Select with Taylor & Francis typically receive 32% more citations* and over 6 times as many downloads** compared to those that are not published Open Select.
Your research funder or your institution may require you to publish your article open access. Visit our Author Services website to find out more about open access policies and how you can comply with these.
You will be asked to pay an article publishing charge (APC) to make your article open access and this cost can often be covered by your institution or funder. Use our APC finder to view the APC for this journal.
Please visit our Author Services website or contact openaccess@tandf.co.uk if you would like more information about our Open Select Program.
*Citations received up to Jan 31st 2020 for articles published in 2015-2019 in journals listed in Web of Science®.
**Usage in 2017-2019 for articles published in 2015-2019.
Peer Review and Ethics
Taylor & Francis is committed to peer-review integrity and upholding the highest standards of review. Once your paper has been assessed for suitability by the editor, it will then be double blind peer-reviewed by independent, anonymous expert referees. Find out more about what to expect during peer review and read our guidance on publishing ethics.
Preparing Your Paper
All authors submitting to medicine, biomedicine, health sciences, allied and public health journals should conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, prepared by the International Committee of Medical Journal Editors (ICMJE).
Authors are strongly encouraged to follow the reporting guidelines on the EQUATOR Network, including, but not limited to, the CONSORT guidelines for randomised studies, the STROBE guidelines for observational studies, the CARE guidelines for case reports, the SAMPL guidelines for statistical reporting, and the PRISMA guidelines for systematic reviews. The guidelines should be used in constructing scientific studies, be followed during their conduct, and used as a checklist and included with the manuscript upon submission. They will not be published, but they will serve as supporting evidence that the submission meets the highest standard of quality and transparency in health research.
Finally, good scientific writing practices should be followed. This includes not using “level” in place of “concentration,” using “significant” only when describing a statistical measure, and avoiding claims of primacy or priority (e.g. “We are the first to report…This is the largest amount…This is the highest concentration…etc.”). If important to include for context, authors should consider using language such as “…we were unable to locate prior cases…a higher published concentration…” etc.
For authors whose first language is not English, it is recommended that assistance be obtained prior to submission. This may be a native English speaker who is familiar with scientific writing or the authors may wish to use a commercial service, such as that offered by Taylor & Francis ( https://www.tandfeditingservices.com/).
Article types
Clinical Research Articles, Basic Research Articles, and Poison Centre Research Articles
The body of the article should include the following sections: introduction; materials and methods; results; discussion; conclusions. An advisory maximum word limit of 3,000 words is suggested for an initial original submission, not including a structured abstract of up to 300 words.
Introduction: This section should state the relevance and background to the study, its rationale and main objectives.
Methods: This section should include only information that was available at the time the plan or protocol for the study was being written. You should describe your selection of the observational or experimental participants, identify the methods, apparatus and procedures in sufficient detail to allow others to reproduce the results, and describe statistical methods with enough detail to enable a knowledgeable reader with access to the original data to verify the reported results. Clinical Toxicology requires that studies involving humans, both volunteers and patients, or animals be approved by an institutional review board, in accordance with approved published guidelines, prior to actually performing the research and publishing the data. Details including clinical trial registration number must be provided in the methods section if research includes studies conducted on human volunteers.
Results: Present your results in logical sequence in the text, tables, and illustrations.
Discussion: This should include implications of the findings and their limitations, with reference to all other relevant studies and the possibilities these suggest for future research.
Conclusions: This must summarize the main paper. Ensure that extrapolations are reasonable and that conclusions are justified by the data presented, and indicate if the study design can be generalized to a broader study population.
The appropriate guidelines should be adhered to when reporting on randomised controlled trials (e.g. CONSORT).
Short Communications
Clinical Toxicology will consider for publication, short reports of two or more patients that described new original observations related to acute or chronic clinical, occupational, and forensic toxicology, and adverse drug reactions or drug-drug interactions that have a direct relation to clinical toxicology. Such reports should include a description of the new or unusual features, or observations that generate a hypothesis or support a change in clinical practice.
Short Communications are limited to 1,000 words, not including a structured abstract of up to 200 words. To structure the abstract, use the same terms used to break the text into sections. Listing more than six authors should be justified in the cover letter to the editor, outlining the contribution of each author to the manuscript.
These reports should focus on the observations presented and not include lengthy reviews of the existing medical literature. Tables, figures, and references are not included in the 1,000 word count. There is a maximum of 2 tables or figures. References are normally limited to 10. A statement of informed patient consent, or approval (or exemption statement) by an Investigational Review Board (Human Studies Committee or Ethics Committee or Animal Care and Use Committee) must normally be submitted with the manuscript.
Manuscripts must meet one of the following criteria:
i. Unexpected or unusual presentations of toxicity;
ii. New associations or variations in toxicity related disease processes;
iii. Presentations, diagnoses or management of new and emerging toxicity-related diseases;
iv. An unexpected association between toxin or symptoms;
v. An unexpected event in the course of observing or treating a patient;
vi. Findings that shed new light on the possible treatment or pathogenesis of a toxicity-related disease.
You must make it clear to the Editor what your case adds to the field of clinical toxicology. In your cover letter, please consider the following: Will it significantly advance our understanding of a particular clinical toxicology syndrome, mechanism, treatment or be supportive of a new hypothesis?
Reviews
Reviews are usually solicited by the Review Editors, but uncommissioned material will also be considered. Please contact the Section Editors, Allister Vale or Michael Mullins before writing a review for the Journal to ensure that the topic is appropriate for the Journal and does not conflict with another review. All reviews, whether solicited or not, will undergo the same peer review and editorial process as original research reports.
Reviews should provide a scholarly, evidence-based, critical analysis of topics relevant to practicing clinical toxicologists and other clinicians and scientists at the interface with acute care, occupational and environmental medicine, public health, regulatory toxicology, pharmacology and pharmaceutics, and analytical and forensic pathology. It is essential that details of the literature search methodology are provided, i.e. the databases searched (normally MEDLINE and at least one or preferably two other databases), the search terms and inclusive dates, and any selectivity criteria imposed.
Authors may include previously unpublished data that may help to clarify an ongoing controversy.
Major reviews
These should either:
i. Focus on a specific toxicological issue of importance (3,500-5,000 words, not including a structured abstract of up to 600 words and up to 100 references). See de Lange DW, Sikma MA, Meulenbelt J. Extracorporeal membrane oxygenation in the treatment of poisoned patients. Clin Toxicol 2013; 51: 385–393; or
ii. Provide a comprehensive overview of an important area of toxicology, with due emphasis being given to developments during the past five years (5,000-10,000 words including a structured abstract of 600 words and up to 150 references). See Schep L, Knudsen K, Slaughter RJ, Vale JA, Mégarbane B. The clinical toxicology of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol. Clin Toxicol 2012; 50: 458–470.
Focused reviews are particularly welcome as readers find these to be of great assistance in their clinical practice.
Mini-reviews
Mini-reviews should summarize the evidence base (maximum 3,000 words, not including a structured abstract of up to 400 words and up to 50 references) that answers a specific question or controversy in clinical toxicology.
Mini-reviews are often based on keynote presentations at an EAPCCT Congress or NACCT meeting. See Brent J. Water-based solutions are the best decontaminating fluids for dermal corrosive exposures: a mini-review. Clin Toxicol 2013; 51:731-36.
Toxicological History
Focused articles with broad appeal on the history of substances, events or persons relevant to clinical, occupational, environmental or forensic toxicology are considered. The main text should not exceed 3,000 words, not including a structured abstract of up to 300 words and at most 50 references.
Teaching Case
Articles in this section are solicited from experts for discussion and guidance regarding clinical decision-making points. Please send a query to the editor before submitting a manuscript in this category. The main text should not exceed 2,000 words, not including a structured abstract of up to 300 words, 2-3 figures or tables, and 20 references.
Images
The focus of the manuscript is original photographs (1-2 high quality figures) of classic, interesting or unusual findings that facilitate the clinical or laboratory diagnosis of toxicological disease. The title should be short and descriptive. The text should be a description of the patient presentation, followed by relevant teaching points and the final diagnosis. Images may include physical findings, radiographs or microscopy and should have a descriptive legend. Use labels and arrows to identify points of interest on the image and remove any identifying patient information. There is no charge for color images published in this section. The main text should not exceed 750 words, not including a structured abstract of up to 150 words and at most 5 references. No more than 3 authors may be listed. This category should not be used as a substitute for Short Communications or Case Reports .
Case Reports/Letter to the Editor/Original Scientific Contribution
……
更多详情：
https://www.tandfonline.com/action/authorSubmission?show=instructions&journalCode=ictx20
